The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people ...
The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% ...
The FDA detected 14 cases of vitamin B6 deficiency–linked seizures and two deaths in patients with Parkinson’s disease taking ...
That’s not for lack of opportunity. Japan’s scientists continue to produce Nobel Prize–winning breakthroughs and the country ...
Healthcare investor Kevin Tang and his allies now hold almost every leadership position at Aurinia Pharmaceuticals, the ...
Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with ...
Earendil Labs’ AI-centered platform has produced more than 40 programs, including anti-inflammatory assets that have attracted a pair of partnership agreements with Sanofi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results